Drugs / zaltoprofen
zaltoprofen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01369238 | Jun 2011 → Jan 2012 | nervous system injury | Korean Pharmacoacupuncture Institute | Unknown | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | zaltoprofen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01369238 ↗ |
| Known as | CN-100 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1765291 ↗ |
| Known as | Peon | ChEMBL registry synonym — accepted as the source's own label CHEMBL1765291 ↗ |
| Known as | Soreton | ChEMBL registry synonym — accepted as the source's own label CHEMBL1765291 ↗ |
| Known as | Zaltoprofene | ChEMBL registry synonym — accepted as the source's own label CHEMBL1765291 ↗ |
| Known as | Zaltoprofeno | ChEMBL registry synonym — accepted as the source's own label CHEMBL1765291 ↗ |
| Modality | Small molecule | — CHEMBL1765291 ↗ |
| Route | Oral | “per os 1Tab tid” NCT01369238 ↗ |